 To achieve the clinical potential of RNAi, siRNA must be efficiently transportated to the cells of target tissues.However, there are various barriers that must be fixed before it can be used clinically.For example, "naked" siRNA is susceptible to several obstacles that reduce its therapeutic efficacy.